AZTR

Conviction 0Scan · Mon, Aug 10, 2026

AZTR$0.1382+2.37%

ResistanceSupportVol 14

Vol MA14 1.43M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Azitra, Inc.PHARMACEUTICAL PREPARATIONSwww.azitrainc.com ↗

Price0.1382

Change+2.37%

Gap+1.63%

Rel volume0.19×

Avg volume1.66M

Avg $ vol223.23K

SMA 200.1334

SMA 500.1670

SMA 2000.2492

Price vs 50-17.25%

Price vs 200-44.55%

MA stackbearish

50/200 cross—

Supertrenddown · 0.1645

RSI (14)46

MACD hist0.00

MACD cross—

Stoch %K / %D61 / 49

ADX (14)9

+DI / −DI24 / 17

RSI divergenceBullish

MACD divergenceBullish

ATR %+8.31%

ADR %6.50%

52w high1.07

52w low0.1263

From 52w high-87.08%

Above 52w low+9.42%

New 52w highNo

SqueezeOn · 8d

Bollinger width14.73%

%B0.75

Donchian pos60.06%

Donchian high0.1505

Donchian low0.1197

AVWAP (52w high)0.3559

vs AVWAP high-61.17%

AVWAP (52w low)0.2507

vs AVWAP low-44.88%

OBV trendFlat

Chaikin MF (20)-0.19

Today vs 20d0.19×

Avg vol (14d)1.43M

Avg vol (20d)1.66M

Avg $ vol (20d)223.23K

Market cap—

RS 3m (vs SPY)-48.90%

RS 6m (vs SPY)-49.67%

RS line new highNo

Trend template0/8

Technical rank20.4

1 week+4.30%

1 month-2.68%

3 months-41.02%

6 months-33.56%

1 year-17.69%

YTD-50.41%

P/E-0.20

P/B0.21

P/S—

P/FCF-0.19

EPS-2.25

Div yield—

ROE-104.53%

ROA-90.34%

Debt/Eq—

Current6.94

EV/EBITDA0.73

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-22.17%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-7.9M

Revenue0

Net income-3.93M

Gross profit—

Free cash flow-11.25M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out16.19M

Employees13

ListedFri, Jun 16, 2023

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank20.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.2403

Support0.1224

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AZTR

All disclosures →

No recent disclosed trades by Congress in AZTR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AZTR · 4 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Salva Francisco D. President and CEO · Common Stock · 2026-06-16	Convert	4.06M	—	2026-06-16	2026-06-18
Salva Francisco D. President and CEO · Series A Convertible Non-Redeemable Preferred Stock · 2026-06-16	Convert	500	—	2026-06-16	2026-06-18
Whitfill Travis Chief Operating Officer · Stock Options (Right To Buy) · 2026-04-20	Grant	64.3K	$0	2026-04-20	2026-04-22
Salva Francisco D. President and CEO · Stock Options (Right To Buy) · 2026-04-20	Grant	220.88K	$0	2026-04-20	2026-04-22
Staskey Norm Chief Financial Officer · Stock Options (Right To Buy) · 2026-04-20	Grant	35.52K	$0	2026-04-20	2026-04-22

SEC filings

EDGAR filings in AZTR · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.